Abstract
Aim: To investigate the mechanism(s) by which the intestinal commensal microbe Lactobacillus acidophilus can affect host immunity, we studied the role of a component of the cell wall, lipoteichoic acid, in colitis. Materials & methods: Colitis was induced by the intraperitoneal injection of pathogenic CD4 +CD25 -CD45RB hi T cells into Rag1 -/- mice. The parental strain, NCK56, or the lipoteichoic acid-deficient strain, NCK2025, was then administered orally. Fluorescent microscopy was employed to examine resulting cell populations and their cytokine production in the colon. Results: NCK2025 enhanced IL-10 production by dendritic cells and macrophages. Increased numbers of regulatory dendritic cells coincided with the induction of activated FoxP3 + Tregs. Conclusion: These results suggest that the oral administration of the genetically modified strain NCK2025 may be an effective immunotherapeutic approach that reprograms the immune response in colonic inflammatory conditions.
Original language | English (US) |
---|---|
Pages (from-to) | 151-161 |
Number of pages | 11 |
Journal | Immunotherapy |
Volume | 4 |
Issue number | 2 |
DOIs | |
State | Published - Feb 2012 |
Externally published | Yes |
Keywords
- Lactobacillus acidophilus
- Tregs
- dendritic cells
- macrophages
- regulatory innate immune cells
ASJC Scopus subject areas
- Oncology
- Immunology and Allergy
- Immunology